iAnthus Capital Holdings (IAN-CSE) Rating
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Stockchase rating for iAnthus Capital Holdings is calculated according
to the stock experts' signals. A high score means experts
mostly recommend to buy the stock while a low score means
experts mostly recommend to sell the stock.
iAnthus Capital Holdings (IAN-CSE) Frequently Asked Questions
What is iAnthus Capital Holdings stock symbol?
iAnthus Capital Holdings is a OTC stock, trading under the symbol
IAN-CSE on the
().
It is usually referred to as
or IAN-CSE
Is iAnthus Capital Holdings a buy or a sell?
In the last year, there was no coverage of iAnthus Capital Holdings
published on Stockchase.
Is iAnthus Capital Holdings a good investment or a top pick?
iAnthus Capital Holdings was never recommended as a Top Pick
on Stockchase.
Read the latest stock experts ratings for iAnthus Capital Holdings .
Why is iAnthus Capital Holdings stock dropping?
Earnings reports or recent company news can cause the stock price to drop.
Read stock experts’ recommendations
for help on deciding if you should buy, sell or hold the stock.
Is iAnthus Capital Holdings worth watching?
In the last year, there was no coverage of iAnthus Capital Holdings
published on Stockchase.
What is iAnthus Capital Holdings stock price?
On , iAnthus Capital Holdings (IAN-CSE)
stock closed at a price of $.
Comparable to Medmen Enterprises. American-based sales of legal cannabis, with operations in six states, including the 48 million people of Massachusetts, Florida and New York. They have one of the 10 licenses in New York and one of the 13 in Florida. This is one of her largest holdings. Â There have been several catalysts recently in the United States. For example New York state’s Department of Health recommended that anyone with an opioid addiction be allowed to access cannabis as an alternative, and generally recommended legalization of recreational cannabis. The opioid crisis affects 4% of the US population, so this presents a large opportunity for cannabis sellers. This company locates is dispensaries in prime areas.